Tokyo, Japan

Masayuki Jinbo

This inventor holds 4 USPTO granted patents. Top assignees: Seikagaku Corporation, Seikagaku Kogyo Kabushiki Kaisha. Active years: 1998-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 1998-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Masayuki Jinbo: Innovator in Medicinal Chemistry

Introduction

Masayuki Jinbo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aminoalcohol derivatives. With a total of 4 patents to his name, Jinbo's inventions focus on developing new therapeutic agents for treating neuronal diseases.

Latest Patents

Among his latest patents is an aminoalcohol derivative and medicament comprising the same. This invention presents an aminoalcohol derivative that acts as a ceramide analogue, which is particularly useful in creating a medicament aimed at treating neuronal diseases and protecting the brain. Another notable patent is the amino alcohol derivative and method for preparing the same, which further showcases his expertise in this area.

Career Highlights

Throughout his career, Masayuki Jinbo has worked with notable companies, including Seikagaku Kogyo Kabushiki Kaisha and Seikagaku Corporation. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medicinal chemistry.

Collaborations

Jinbo has collaborated with esteemed colleagues such as Jinichi Inokuchi and Hidekazu Oyamada. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Masayuki Jinbo's contributions to medicinal chemistry through his innovative patents highlight his dedication to advancing healthcare solutions. His work continues to influence the field and offers promising avenues for future research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…